Effect of methandrostenolone on serum triglyceride and cholesterol levels in diabetic patients.
Eighteen adult diabetic patients were treated with methandrostenolone in daily doses of 15 mg for 3 weeks. Serum triglyceride and cholesterol levels and lipoprotein lipase activity were determined before and after treatment. In patients with intense hypertriglyceridaemia, triglyceride concentration decreased and, with the exception of a single patient, lipoprotein lipase activity returned to normal. Cholesterol concentration did not change characteristically.
D001786:Blood Glucose; D001835:Body Weight; D002784:Cholesterol / Q000097:blood*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood* / Q000188:drug therapy; D005260:Female; D006029:Glycosuria; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications; D008071:Lipoprotein Lipase / Q000097:blood; D008297:Male; D008696:Methandrostenolone / Q000494:pharmacology* / Q000627:therapeutic use; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood*
D001786:Blood Glucose; D014280:Triglycerides; D002784:Cholesterol; D008696:Methandrostenolone; D008071:Lipoprotein Lipase